This work reveals that dysregulation of LINC00152 in ovarian cancer predicts poor survivals of patients, and the stabilization of BCL6 by LINC00152 promotes ovarian tumor proliferation and invasion. The gene discussed is BCL6; the disease is ovarian neoplasm.